Published in Clin Exp Allergy on June 03, 2008
Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA (2008) 6.24
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD. Int J Chron Obstruct Pulmon Dis (2015) 1.02
Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy. Allergy Asthma Immunol Res (2015) 0.97
Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology. Respir Res (2011) 0.96
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int J Chron Obstruct Pulmon Dis (2015) 0.91
Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis (2009) 0.83
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly. Clin Mol Allergy (2015) 0.82
The Skeletal Effects of Inhaled Glucocorticoids. Curr Osteoporos Rep (2016) 0.75
Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis. BMJ Open (2015) 0.75
Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Pharmacotherapy in the management of asthma in the elderly: a review of clinical studies. Asia Pac Allergy (2016) 0.75
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Effect of aquaculture on world fish supplies. Nature (2000) 8.98
BioJava: an open-source framework for bioinformatics. Bioinformatics (2008) 6.17
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
Human monoclonal antibody production. Current status and future prospects. J Immunol Methods (1987) 2.21
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Laboratory staff qualifications and accuracy of proficiency test results. A national study. Arch Pathol Lab Med (1992) 2.07
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
The natural history of Peyronie's disease. J Urol (1990) 2.02
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
Psychotic men remanded in custody to Brixton Prison. Br J Psychiatry (1994) 1.77
Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54
Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy (2004) 1.51
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J (2004) 1.50
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Is allergen exposure the major primary cause of asthma? Thorax (2000) 1.48
The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48
The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48
A study of the management of asthma in a hospital emergency department. N Z Med J (1989) 1.47
Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol (2001) 1.46
[Surgical treatment of the single non traumatic perforation of small bowel: excision-suture or resection-anastomosis]. Ann Chir (2005) 1.45
Sudden unexpected death in infancy. A new hypothesis of cause. Clin Pediatr (Phila) (1966) 1.44
Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43
Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43
Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42
Continuous thoracic epidural analgesia versus combined spinal/thoracic epidural analgesia on pain, pulmonary function and the metabolic response following colonic resection. Acta Anaesthesiol Scand (1996) 1.42
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41
Use of a management plan for treating asthma in an emergency department. Thorax (1990) 1.40
Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40
Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax (1997) 1.39
Fenoterol and asthma death. N Z Med J (1989) 1.39
Asthma deaths in New Zealand. BMJ (1992) 1.38
Fenoterol: confounding again. N Z Med J (1989) 1.38
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
Inappropriate use of inhaled beta agonists in asthma. N Z Med J (1990) 1.37
Prescribing for childhood asthma in the Wellington area: comparison with international guidelines. N Z Med J (1993) 1.37
The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. Am Rev Respir Dis (1987) 1.33
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32
Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. Br Med J (Clin Res Ed) (1985) 1.30
Characterization of antilymphocytic antibody. Nature (1967) 1.27
Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27
Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg (1993) 1.26
The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol (1983) 1.25
Measuring the prevalence of bronchial hyper-responsiveness in children. Int J Epidemiol (1995) 1.24